Cargando…
MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas
Pituitary adenoma (PA) accounts for 10–15% of all intracranial neoplasms. Even though most pituitary adenomas are benign, it is known that almost 35% of them exhibit an aggressive clinical course, including rapid proliferative activity and invasion of neighboring tissues. MicroRNAs (miRNAs) are shor...
Autores principales: | Beylerli, Ozal, Beeraka, Narasimha M., Gareev, Ilgiz, Pavlov, Valentin, Yang, Guang, Liang, Yanchao, Aliev, Gjumrakch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583927/ https://www.ncbi.nlm.nih.gov/pubmed/33023145 http://dx.doi.org/10.3390/ijms21197287 |
Ejemplares similares
-
The Role of Long Non-Coding RNAs in Intracranial Aneurysms and Subarachnoid Hemorrhage
por: Gareev, Ilgiz, et al.
Publicado: (2020) -
Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas
por: Beylerli, Ozal, et al.
Publicado: (2021) -
COVID-19-Related Intracerebral Hemorrhage
por: Pavlov, Valentin, et al.
Publicado: (2020) -
The Role of Mitochondria-Targeting miRNAs in Intracerebral Hemorrhage
por: Gareev, Ilgiz, et al.
Publicado: (2023) -
Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status
por: Bulygin, Kirill V., et al.
Publicado: (2020)